Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and fluorodeoxyglucose f18

capecitabine has been researched along with fluorodeoxyglucose f18 in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (10.71)29.6817
2010's21 (75.00)24.3611
2020's4 (14.29)2.80

Authors

AuthorsStudies
Cheng, JD; Cohen, SJ; Eisenberg, D; Engstrom, P; Freedman, G; Haluszka, O; Hoffman, J; Konski, A; McGarrity, E; Meropol, NJ; Sigurdson, E; Watson, JC1
Cohen, SJ; Konski, A; Li, T; Meropol, NJ; Sigurdson, E; Small, W; Spies, S; Stryker, S; Wahl, A; Yu, JQ1
Arens, A; Beets, GL; Beets-Tan, RG; Buijsen, J; de Ruysscher, D; Driessen, A; Kessels, AG; Lammering, G; Oellers, M; van Baardwijk, A; Vanhauten, B; Vliegen, RF1
Jung, SY; Kang, HS; Kim, EA; Kim, SK; Kim, SW; Ko, KL; Kwon, Y; Lee, KS; Lee, S; Lee, SJ; Min, SY; Nam, BH; Park, C; Park, IH; Ro, J; Shin, KH1
Buijsen, J; de Ruysscher, D; Janssen, MH; Lambin, P; Lammering, G; Ollers, MC; van den Bogaard, J; van Stiphout, RG1
Aklilu, M; Blackstock, AW; Clark, P; Geisinger, KR; Isom, S; Levine, EA; Mishra, G; Monjazeb, AM; Riedlinger, G1
Baghel, NS; Basu, S1
Abel, U; Debus, J; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lorenzen, S; Münter, MW; Stange, A; von Gall, C; Weichert, W; Weitz, J1
Helin, H; Karhumäki, L; Kauppi, JT; Kemppainen, J; Oksala, N; Räsänen, JV; Salo, JA; Sihvo, EI1
Arrangoiz, R; Cooper, H; Farma, JM; Konski, A; Li, T; Nitzkorski, JR; Shanmugan, S; Sigurdson, ER; Yu, JQ1
Bernstine, H; Brenner, B; Goldberg, N; Gordon, N; Groshar, D; Idelevich, E; Kundel, Y; Morgenstern, S; Purim, O; Sulkes, A; Wasserberg, N1
Knox, JJ; Zhu, AX1
Alessi, A; Avuzzi, B; Bampo, C; Bertarelli, G; Biondani, P; Bombardieri, E; Chiruzzi, C; Crippa, F; de Braud, F; Di Bartolomeo, M; Fantini, S; Mariani, L; Milione, M; Pietrantonio, F; Valvo, F1
Bilic, S; Burris, HA; de Vries, EG; Gietema, JA; Goldbrunner, M; Infante, JR; Oldenhuis, CN; Parker, K; Scott, JW; Sharma, S; Yang, L1
Benzon, EV; Brünner, N; Christensen, IJ; Engelmann, BE; Gerds, TA; Hansson, SH; Holländer, NH; Højgaard, L; Kjær, A; Kristensen, MH; Löfgren, J; Loft, A; Markova, E; Nielsen, HJ; Sloth, C1
Aiba, T; Kato, K; Nagino, M; Nihashi, T; Tsuzuki, T; Uehara, K; Yatsuya, H; Yoshioka, Y1
Bang, JI; Ha, S; Kang, SB; Kim, JS; Kim, SE; Lee, HS; Lee, HY; Lee, KW; Oh, HK1
Li, BS; Shi, H; Wang, J; Wen, M; Xiao, MY1
Ameye, L; Delaunoit, T; Deleporte, A; Demolin, G; Flamen, P; Garcia, C; Gauthier, N; Guiot, T; Hendlisz, A; Holbrechts, S; Lhommel, R; Maréchal, R; Van den Eynde, M; Vierasu, I; Woff, E1
Ashwathanarayana, AG; Biswal, CK; Kapoor, R; Mittal, BR; Parihar, AS; Sood, A1
Alessi, A; Battiston, C; Berenato, R; Caporale, M; Coppa, J; Cotsoglou, C; de Braud, F; Delconte, G; Di Bartolomeo, M; Fucà, G; Greco, G; Infante, G; Lazzati, S; Mazzaferro, V; Mennitto, A; Morano, F; Niger, M; Padovano, B; Pellegrinelli, A; Pietrantonio, F1
Carter, BW; Goense, L; Ho, L; Hofstetter, WL; Lin, SH; Maru, DM; Meijer, GJ; van Hillegersberg, R; van Rossum, PSN; Xi, M1
Ålgars, A; Kemppainen, J; Ristamäki, R; Salminen, P; Sundström, J; Vihervaara, H1
Caruso, R; Diaz Reques, E; Duran Gimenez Rico, H; Fabra Cabrera, I; Ferri, V; Garcerant, M; Garcia Cañamaques, L; Ielpo, B; Isernia, R; Malavè Cardozo, L; Perez Dueñas, V; Pinna, E; Plaza Hernandezv, C; Quijano Collazo, Y; Vicente Lopez, E1
Basu, S; Bhandare, MS; Bhargava, P; Chaudhari, V; Ostwal, V; Parghane, RV; Ramaswamy, A; Shah, M; Shrikhande, SV; Srinivas, S1
Goto, Y; Iwase, T; Tanaka, H1
Bodei, L; Bongiovanni, A; Caroli, P; Cittanti, C; Di Iorio, V; Diano, D; Grana, CM; Grassi, I; Ibrahim, T; Monti, M; Nicolini, S; Paganelli, G; Pieri, F; Sansovini, M; Sarnelli, A; Severi, S1
Aoyama, T; Atsumi, Y; Ju, M; Kazama, K; Numata, M; Rino, Y; Tamagawa, H; Tsuchiya, K; Yukawa, N1

Trials

6 trial(s) available for capecitabine and fluorodeoxyglucose f18

ArticleYear
Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy.
    Annals of surgical oncology, 2010, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Taxoids; Treatment Outcome; Young Adult

2010
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Oncology, 2013, Volume: 84, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2013
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
    The oncologist, 2014, Volume: 19, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed

2014
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sorafenib; Treatment Outcome

2016
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
    Oncology, 2017, Volume: 93, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Positron Emission Tomography Computed Tomography; Postoperative Care; Preoperative Care; Stomach Neoplasms

2017
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:10

    Topics: Capecitabine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies

2021

Other Studies

22 other study(ies) available for capecitabine and fluorodeoxyglucose f18

ArticleYear
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
    Seminars in oncology, 2005, Volume: 32, Issue:6 Suppl 9

    Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Radiotherapy; Rectal Neoplasms

2005
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
    International journal of radiation oncology, biology, physics, 2009, May-01, Volume: 74, Issue:1

    Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Statistics, Nonparametric

2009
Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2008, Volume: 184, Issue:9

    Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Deoxycytidine; Fascia; Fasciotomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Software; Survival Rate; Tomography, X-Ray Computed

2008
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 94, Issue:2

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome

2010
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Nov-01, Volume: 28, Issue:31

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Contrast Media; Deoxycytidine; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Treatment Outcome

2010
Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.
    Japanese journal of radiology, 2011, Volume: 29, Issue:4

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Positron-Emission Tomography; Radiopharmaceuticals

2011
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    BMC cancer, 2011, Jun-24, Volume: 11

    Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Germany; Humans; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Taxoids; Treatment Outcome

2011
Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Taxoids; Tomography, X-Ray Computed

2012
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Annals of surgical oncology, 2012, Volume: 19, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed

2012
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study.
    Radiation oncology (London, England), 2012, Aug-01, Volume: 7

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil

2012
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
    The oncologist, 2012, Volume: 17, Issue:12

    Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Biopsy; CA-125 Antigen; Capecitabine; Carcinoembryonic Antigen; Carrier Proteins; CDX2 Transcription Factor; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cytokines; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Glycoproteins; Hepatectomy; Homeodomain Proteins; Humans; Immunohistochemistry; Keratin-20; Keratins; Liver; Liver Neoplasms; Lymph Node Excision; Magnetic Resonance Imaging; Membrane Transport Proteins; Phenotype; Portal Vein; Pregnancy; Receptors, Estrogen; Receptors, Progesterone

2012
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors.
    Investigational new drugs, 2014, Volume: 32, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Demography; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Receptors, TNF-Related Apoptosis-Inducing Ligand

2014
MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Annals of surgical oncology, 2014, Volume: 21, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaloacetates; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Treatment Outcome

2014
Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Imaging, Three-Dimensional; Leucovorin; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome

2016
Widespread lymph node recurrence of major duodenal papilla cancer following pancreaticoduodenectomy.
    World journal of gastroenterology, 2015, Dec-28, Volume: 21, Issue:48

    Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Oxaliplatin; Pancreaticoduodenectomy; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2015
Imaging-Guided Use of Combined
    Journal of nuclear medicine technology, 2017, Volume: 45, Issue:4

    Topics: Adult; Capecitabine; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided

2017
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
    Annals of surgical oncology, 2018, Volume: 25, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nomograms; Oxaliplatin; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Radiotherapy Dosage; Risk Assessment; Sex Factors; Survival Rate

2018
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology.
    Surgical oncology, 2019, Volume: 28

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult

2019
Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study.
    Acta oncologica (Stockholm, Sweden), 2019, Volume: 58, Issue:9

    Topics: Antimetabolites, Antineoplastic; Area Under Curve; Capecitabine; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; ROC Curve

2019
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG Uptake.
    Neuroendocrinology, 2021, Volume: 111, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Drug Combinations; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Peptide; Retrospective Studies; Temozolomide

2021
[Disseminated Bone Marrow Carcinomatosis from Breast Cancer Improved by Capecitabine-A Clinical Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:1

    Topics: Bone Marrow; Breast Neoplasms; Capecitabine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography

2021
[A Case of Rectal Cancer with Brain and Skin Metastasis with Long-Term Survival Managed by Multidisciplinary Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain; Capecitabine; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Positron Emission Tomography Computed Tomography; Rectal Neoplasms

2022